Educational reference

Peptide library

DSIP

Your guide to this compound.

Dosing and concentration

Experimental dose information: 100–500 micrograms near bedtime is not an established insomnia prescription. Do not keep taking extra amounts during the night because sleep has not arrived.

A microgram is one-thousandth of a milligram. Record the actual peptide amount and concentration, not only syringe markings. A concentration calculator can check a documented volume, but it cannot tell someone which amount will improve their sleep or when redosing is appropriate.

Preparation and reconstitution

DSIP may be supplied as lyophilised, meaning freeze-dried, material. Reconstitution needs instructions for the exact preparation: compatible diluent, liquid volume, resulting concentration and discard limit. Bacteriostatic water is not a universal recipe for making a sleep medicine.

Its preservative, usually benzyl alcohol, does not sterilise a research vial. Water that dissolves a peptide does not establish that the resulting solution is safe for injection or suitable for nasal use. Those routes require different formulation considerations.

Do not add sedatives or other peptides to the same vial, and do not prepare a nasal spray from injection instructions. Label any documented preparation clearly with compound, concentration, route and dates. Preparing or measuring a product while already drowsy increases the chance of a mistake.

Administration

Amounts delivered into a vein cannot be copied into a SubQ injection or nasal spray. These routes require separate preparations and instructions. Do not select a home injection method from a different route’s dose.

If a clinician is supervising a documented preparation, they should demonstrate its actual device and handling. Use clean hands and new sterile equipment, rotate suitable sites and dispose of sharps immediately. These steps address handling risks; they do not establish that the peptide will improve sleep.

Do not drive or perform hazardous tasks if a new product makes you drowsy or dizzy. Alcohol, sedatives and multiple sleep products make changes harder to interpret and can create additional risks. Lack of immediate sleep is not a reason to keep escalating overnight.

Oral versus subcutaneous delivery

Swallowed DSIP can break down during digestion. A capsule, under-the-tongue product and nasal spray cannot be assumed equivalent to an injection. Each needs its own formulation and amount.

For some compounds, an oral route is intended to act locally on gut tissue. DSIP's sleep claims instead concern effects on the nervous system. A local gut explanation does not establish that an oral DSIP product will improve sleep.

Half-life

A dependable half-life for injection under the skin is not available. A minutes-long estimate is not a bedtime or redosing schedule.

Storage

Follow the exact preparation's storage and discard instructions. Lyophilised material and a reconstituted solution need separate guidance. The opening date of bacteriostatic water does not establish the expiry of the peptide mixed with it.

Keep the container labelled and away from children. Do not leave a prepared solution at the bedside without temperature guidance, and do not keep an unlabelled syringe for later use. Unexpected particles, colour changes or damaged packaging need assessment rather than a home attempt to repair the preparation.

Contraindications and side effects

Long-term risks and interactions are not fully known. If you have sleep apnoea, breathing disease, unexplained daytime sleepiness or take sedating medicines, seek medical review before adding a sleep-active product. Pregnancy and breastfeeding also require review.

Headache, dizziness, unexpected alertness, poor sleep or next-day impairment should be recorded rather than dismissed. A very small literature cannot establish the absence of dependence or withdrawal risks. DSIP should not be promoted as a do-it-yourself treatment for alcohol or opioid withdrawal.

Seek urgent help for breathing difficulty, severe confusion, fainting or a serious allergic reaction. Fever or spreading redness after an injection needs assessment. Persistent insomnia deserves treatment even when a wearable appears to show normal sleep duration.

Tracking progress and common questions

Record bedtime, estimated time to fall asleep, awakenings, waking time and next-day function. Add caffeine, alcohol, illness and unusual stress. Look for a sustained pattern rather than one excellent or terrible night.

“Does the name guarantee deep sleep?” No. “Should I chase a wearable's sleep-stage number?” No: symptoms and function matter, and wearables estimate stages. “Can DSIP replace an assessment for snoring and gasping?” No: sleep-disordered breathing needs its own diagnosis and treatment.

Open image for full-resolution zoom